Literature DB >> 11666049

The treatment of internal anal sphincter achalasia with botulinum toxin.

A Messineo1, D Codrich, M Monai, S Martellossi, A Ventura.   

Abstract

Internal anal sphincter (IAS) achalasia is a disorder of defecation in which the IAS fails to relax. Botulinum toxin (BT), which has been successfully used to relax the anal and lower esophageal sphincters, was injected twice into the IAS of one adolescent and three infants with manometric, radiologic, and in 2 cases histochemical diagnosis of anal achalasia: in the adolescent a third injection was necessary. Spontaneous defecation was achieved in all patients following the second injection. In one case a diagnosis of short-segment Hirschsprung's disease was obtained after the second injection. Local infiltration of BT into the IAS proved effective in the treatment of IAS achalasia. Double-blind studies and longer follow-up periods are needed to better evaluate these preliminary results and define the limits of this promising therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11666049     DOI: 10.1007/s003830100583

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  12 in total

1.  Hirschsprung's Disease.

Authors:  William M. Belknap
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

Review 2.  Classification and diagnostic criteria of variants of Hirschsprung's disease.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

3.  Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung's disease.

Authors:  A I Koivusalo; M P Pakarinen; R J Rintala
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

4.  Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction.

Authors:  Katy Irani; Leonel Rodriguez; Daniel P Doody; Allan M Goldstein
Journal:  Pediatr Surg Int       Date:  2008-04-29       Impact factor: 1.827

5.  Comparison of posterior internal anal sphincter myectomy and intrasphincteric botulinum toxin injection for treatment of internal anal sphincter achalasia: a meta-analysis.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2012-08       Impact factor: 1.827

6.  Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children.

Authors:  Ricardo A Arbizu; Leonel Rodriguez
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

7.  Treatment Options for Refractory Childhood Constipation.

Authors:  Nader N. Youssef; Carlo Di Lorenzo
Journal:  Curr Treat Options Gastroenterol       Date:  2002-10

8.  Botulinum toxin use in paediatric colorectal surgery.

Authors:  S Basson; P Charlesworth; C Healy; S Phelps; Stewart Cleeve
Journal:  Pediatr Surg Int       Date:  2014-07-06       Impact factor: 1.827

9.  Effect of botulinum-A toxin to cremaster muscle: an experimental study.

Authors:  Murat Cakmak; Fatma Cağlayan; Ali Kemal Erdemoğlu; Sevgi Ulusoy
Journal:  Urol Res       Date:  2003-09-04

10.  Long-term outcome of internal sphincter myectomy in patients with internal anal sphincter achalasia.

Authors:  Reshma Doodnath; Prem Puri
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.